Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-06-10

FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s supplemental application for escitalopram (generic) under ANDA202389. This approval marks a supplemental approval to the o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM)